Mulmit

Grace Therapeutics, Inc.Grace Therapeutics, Inc.

GRCE Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2022-03-310-15,589,000-9,819,000-0.27
2021-03-31196,000-16,419,000-19,678,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-09Opaleye Management Inc.5,836
2026-09-09Kohli PrashantChief Executive Officer100,000
2026-09-08Opaleye Management Inc.9,393
2026-08-28Kohli PrashantChief Executive Officer267,160
2026-08-28Kumar AmreshVP Program Management35,760
2026-08-28Macdonald R. LochChief Medical Officer54,690
2026-08-28DelAversano Robert JPrincipal Financial Officer33,660
2026-08-14Opaleye Management Inc.11,608
2026-01-08Kavuru Vimal10,000
2026-01-08Kottayil George10,000
2026-01-08NEUGEBOREN EDWARD10,000
2026-01-08DAVIS A BRIAN10,000

8-K events

FiledItems
2026-08-13Results of operations · Financial statements and exhibits
2026-08-06Entry into a material agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2026-07-28Other events · Financial statements and exhibits
2026-06-18Other events · Financial statements and exhibits
2026-06-18Results of operations · Financial statements and exhibits
2026-06-05Officer or director change · Financial statements and exhibits
2026-04-27Other events · Financial statements and exhibits
2026-04-23Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…